Patents by Inventor Deborah Quaglio

Deborah Quaglio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220259249
    Abstract: The present invention relates to diterpene compounds of general formula (I) capable of contrasting the antibiotic-resistance mediated by the ArnT enzyme, to their use as a medicament, in particular for use as an adjuvant of an antibiotic therapy in the treatment of antibiotic-resistant bacterial infections. The invention relates also to associations of one or more of the compounds of formula (I) with at least another active ingredient, in particular an antibacterial agent and/or an antibiotic, and compositions comprising one or more compounds of formula (I) or the association according to the present invention and at least one pharmaceutically acceptable excipient and/or carrier as well as to products, in particular medical devices, comprising at least a compound, an association or a composition according to the present invention.
    Type: Application
    Filed: July 24, 2020
    Publication date: August 18, 2022
    Applicants: UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA", FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
    Inventors: Francesco IMPERI, Fiorentina ASCENZIONI, Mattia MORI, Francesca GHIRGA, Deborah QUAGLIO, Silvia CORRADI, Alessandra LO SCIUTO, Bruno BOTTA, Andrea CALCATERRA, Roberta STEFANELLI
  • Publication number: 20210363121
    Abstract: Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
    Type: Application
    Filed: August 9, 2021
    Publication date: November 25, 2021
    Inventors: Bruno Botta, Isabella Screpanti, Luca Tottone, Nadezda Zhdanoskaya, Cinzia Ingallina, Francesca Giulimondi, Deborah Quaglio, Rocco Palermo, Mattia Mori, Francesca Ghirga
  • Patent number: 11104657
    Abstract: Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: August 31, 2021
    Assignees: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, UNIVERSITÀ DEGLI STUDI DI ROMA “LA SAPIENZA”
    Inventors: Bruno Botta, Isabella Screpanti, Luca Tottone, Nadezda Zhdanoskaya, Cinzia Ingallina, Francesca Giulimondi, Deborah Quaglio, Rocco Palermo, Mattia Mori, Francesca Ghirga
  • Publication number: 20210030714
    Abstract: The present invention relates to a compound of formula (1): or an analogue thereof or a pharmaceutically acceptable salt thereof, for use in the treatment of a brain tumor, wherein the compound is administered intranasally and relative pharmaceutical compositions.
    Type: Application
    Filed: February 5, 2019
    Publication date: February 4, 2021
    Applicants: UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA", FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, UNIVERSITA DEGLIS STUDI DI PADOVA
    Inventors: Cristina LIMATOLA, Giuseppina D'ALESSANDRO, Lucia DI MARCOTULLIO, Paola INFANTE, Bruno BOTTA, Mattia MORI, Francesca GHIRGA, Cinzia INGALLINA, Simone BERARDOZZI, Paolo CALICETI, Stefano SALMASO, Michela DE MARTINO, Francesco GASPARRINI, Deborah QUAGLIO
  • Publication number: 20190337916
    Abstract: Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
    Type: Application
    Filed: December 20, 2017
    Publication date: November 7, 2019
    Inventors: Bruno Botta, Isabella Screpanti, Luca Tottone, Nadezda Zhdanoskaya, Cinzia Ingallina, Francesca Giulimondi, Deborah Quaglio, Rocco Palermo, Mattia Mori, Francesca Ghirga